Characteristic | 2016 n (%) | 2017 n (%) | 2018 n (%) | 2019 n (%) | 2020 n (%) | 2016 to 2020 (p)** | |
---|---|---|---|---|---|---|---|
Sex | Female | 17,662 (54.4) | 17,216 (54.1) | 17,372 (54.1) | 16,870 (53.7) | 17,564 (53.0) | < 0.001 |
Male | 14,780 (45.6) | 14,617 (45.9) | 14,726 (45.9) | 14,524 (46.3) | 15,596 (47.0) | ||
Age group | 18–50 | 781 (2.4) | 582 (1.8) | 588 (1.8) | 571 (1.8) | 628 (1.9) | < 0.001 |
51–60 | 2,006 (6.2) | 1,755 (5.5) | 1,784 (5.6) | 1,750 (5.6) | 1,817 (5.5) | ||
61–70 | 3,768 (11.6) | 3,466 (10.9) | 3,614 (11.3) | 3,597 (11.5) | 3,956 (11.9) | ||
71–80 | 8,467 (26.1) | 7,153 (22.5) | 6,965 (21.7) | 6,473 (20.6) | 6,567 (19.8) | ||
81–90 | 12,364 (38.1) | 12,653 (39.7) | 12,602 (39.3) | 12,682 (40.4) | 13,431 (40.5) | ||
> 90 | 5,056 (15.6) | 6,224 (19.6) | 6,545 (20.4) | 6,321 (20.1) | 6,761 (20.4) | ||
Disease group* | HIV/AIDS | 30 (0.1) | 31 (0.1) | 21 (0.1) | 31 (0.1) | 32 (0.1) | 0.967 |
Malignant neoplasms | 11,809 (36.4) | 10,758 (33.8) | 10,793 (33.6) | 10,771 (34.3) | 12,327 (37.2) | 0.041 | |
Heart diseases | 24,546 (75.7) | 23,463 (73.7) | 23,387 (72.9) | 23,018 (73.3) | 24,704 (74.5) | < 0.001 | |
Cerebrovascular diseases | 10,216 (31.5) | 8,798 (27.6) | 8,843 (27.6) | 8,328 (26.5) | 9,517 (28.7) | < 0.001 | |
Renal diseases | 13,219 (40.7) | 12,665 (39.8) | 12,766 (39.8) | 12,714 (40.5) | 14,267 (43.0) | < 0.001 | |
Liver diseases | 5,621 (17.3) | 4,749 (14.9) | 4,699 (14.6) | 4,939 (15.7) | 6,175 (18.6) | < 0.001 | |
Respiratory diseases | 15,284 (47.1) | 14,854 (46.7) | 14,974 (46.7) | 14,876 (47.4) | 16,543 (49.9) | < 0.001 | |
Neurodegenerative diseases | 2,279 (7.0) | 1,937 (6.1) | 1,963 (6.1) | 1,853 (5.9) | 2,159 (6.5) | 0.009 | |
Dementia, Alzheimer’s, senility/frailty | 17,382 (53.6) | 14,825 (46.6) | 15,054 (46.9) | 14,539 (46.3) | 18,076 (54.5) | 0.017 |